IP Library Granted Patent US 11,806,457
Granted Patent B2
US 11,806,457 · App. 16/674,532 · Granted Nov 7, 2023

Peritoneal dialysis adequacy meaurements

Inventors: Martin T. Gerber (Maple Grove, MN); Christopher M. Hobot (Rogers, MN)
Assignee: Mozarc Medical US LLC
A61M1/285G16H20/40A61B5/201A61M2205/3303A61M2205/3334A61M2205/50A61M2230/20A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,806,457
App. No.
16/674,532
Granted
Nov 7, 2023
Kind
B2
Abstract

The invention relates to devices, systems, and methods for measuring dialysis adequacy in patients undergoing peritoneal dialysis treatment. The devices, systems, and methods use one or more flow sensors and one or more solute sensors to measure the concentration of a uremic solute and volume of the peritoneal dialysate removed from the patient, and to calculate the dialysis adequacy based on the measured peritoneal dialysate concentration and volume.

Claims (32)

1. A system, comprising:

a catheter ( 102 ) for removing peritoneal dialysate from a patient; a fluid line ( 107 ) fluidly connected to the catheter, or a reservoir ( 112 ) fluidly connected to the catheter;

one or more flow sensors ( 108 ) in the catheter;

one or more uremic solute sensors ( 109 ) measuring a uremic solute concentration in a peritoneal dialysate removed from the patient;

at least one glucose sensor measuring a glucose concentration in the peritoneal dialysate removed from the patient; and

a processor in communication with the one or more flow sensors and the one or more uremic solute sensors, wherein the processor is programmed to calculate a clearance based on measurements obtained from the one or more flow sensors and the one or more uremic solute sensors; the processor is programmed to cause removal of a portion of dialysate to be removed from the patient during a peritoneal dialysis dwell period;

and the processor further programmed to calculate a diffusion coefficient during the peritoneal dialysis dwell period based on data received from the at least one glucose sensor during the same peritoneal dialysis dwell period.

2. The system of claim 1 , wherein the processor is programmed to calculate a dialysis adequacy using an equation Kt/V; wherein K is equal to clearance, t is time, and V is a patient water volume.

3. The system of claim 1 , the processor programmed to estimate a peritoneal membrane transport capability for the patient based on the data received from the at least one glucose sensor at three or more time points during a peritoneal dialysis cycle.

4. The system of claim 1 , the processor programmed to calculate a total Kt/V for the patient using an equation: total Kt/V is equal to Kt/V from dialysis and Kt/V from residual kidney function.

5. The system of claim 4 , the processor programmed to calculate the Kt/V from residual kidney function using an equation: Kt/V from residual kidney function=U/P×L u /V, wherein U is a uremic solute concentration in urine of the patient, P is a blood uremic solute concentration, and L u is a volume of urine produced.

6. The system of claim 5 , the processor programmed to receive the uremic solute concentration in urine and volume of urine produced from the patient.

7. The system of claim 1 , the processor programmed to estimate the patient water volume based on a patient weight.

8. The system of claim 1 , wherein the one or more uremic solute sensors are positioned in the catheter.

9. The system of claim 1 , wherein the one or more uremic solute sensors are positioned in a fluid line or reservoir fluidly connected to the catheter.

10. The system of claim 1 , wherein the processor calculates a clearance based on measurements obtained from the one or more flow sensors and one or more uremic solute sensors in real-time or nearly real-time.

11. The system of claim 1 , wherein the uremic solute is selected from the group consisting of urea, creatinine, beta-2 microglobulin, uric acid, and combinations thereof.

12. The system of claim 1 , wherein the one or more uremic solute sensors is selected from the group consisting of a urea sensor, a creatinine sensor, a beta-2 microglobulin sensor, a uric acid sensor, and combinations thereof.

13. A method, comprising the steps of:

calculating a clearance based on a uremic solute concentration in a peritoneal dialysate removed from a patient measured by one or more uremic solute sensors ( 109 ) and a volume of peritoneal dialysate removed from the patient measured by one or more flow sensors ( 108 ) in a catheter; and

calculating a diffusion coefficient during a peritoneal dialysis dwell period based on data received from at least one glucose sensor during the same peritoneal dialysis dwell period; wherein the data received from the at least one glucose sensor is a glucose concentration in a portion of peritoneal dialysate removed from the patient during the peritoneal dialysis dwell period.

14. The method of claim 13 , further comprising a step of calculating a dialysis adequacy using an equation Kt/V; wherein K is equal to clearance, t is time, and V is a patient water volume.

15. The method of claim 13 or 14 , wherein the clearance is calculated by an equation clearance=F/P×L, wherein F is the uremic solute concentration in the peritoneal dialysate removed from the patient, P is a blood uremic solute concentration of the patient, and L is the volume of peritoneal dialysate removed from the patient.

16. The method of claim 15 , wherein P is calculated using an equation P=F/(T×D), wherein T is a time point during a peritoneal dialysis cycle and D is the diffusion coefficient for the patient.

17. The method of claim 16 , further comprising a step of estimating a peritoneal membrane transport capability for the patient using an osmotic agent sensor in the catheter, a fluid line fluidly connectable to the catheter, or a reservoir fluidly connectable to the catheter.

18. The method of claim 15 , wherein the uremic solute concentration of the peritoneal dialysate is measured at an end of a peritoneal dialysis cycle, and wherein P is calculated using an equation P=total uremic solute/V; wherein the total uremic solute is calculated using an equation total uremic solute=F*L+F*(V−UF), wherein UF is an ultrafiltration volume for the peritoneal dialysis cycle.

19. The method of claim 13 , wherein the uremic solute concentration in the peritoneal dialysate is measured with the one or more uremic solute sensors ( 109 ) in the catheter, a fluid line ( 107 ) fluidly connectable to the catheter, or a reservoir ( 112 ) fluidly connectable to the catheter.

20. The method of claim 13 , further comprising a step of calculating a Kt/V from residual kidney function.

21. The method of claim 20 , wherein the Kt/V from residual kidney function is calculated using an equation Kt/V from residual kidney function=U/P×L u /V, wherein U is a uremic solute concentration in urine of the patient and L u is a volume of urine produced.

22. The method of claim 20 , further comprising a step of calculating a total Kt/V for the patient using an equation total Kt/V is equal to Kt/V from dialysis and Kt/V from residual kidney function.

23. The method of claim 13 , wherein the step of calculating the clearance is performed by a processor of a peritoneal dialysis system.

24. The method of claim 13 , wherein the uremic solute is selected from the group consisting of urea, creatinine, beta-2 microglobulin, uric acid, and combinations thereof.

Assignments (3)
SECURITY INTEREST Recorded Dec 1, 2025
From: MOZARC MEDICAL US LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V, LP
Reel/Frame 073800/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2023
From: MEDTRONIC, INC.
To: MOZARC MEDICAL US LLC
Reel/Frame 063375/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2019
From: GERBER, MARTIN T.; HOBOT, CHRISTOPHER M.
To: MEDTRONIC, INC.
Reel/Frame 050919/0953 →